{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:44:28Z","timestamp":1793724268450,"version":"4.6.1"},"reference-count":161,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["K12\/NRCDP"],"award-info":[{"award-number":["K12\/NRCDP"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cell Biol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1038\/s41556-026-01972-2","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T09:02:29Z","timestamp":1780304549000},"page":"1364-1378","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Emerging roles of ferroptosis in modulating the immune landscape of glial tumours"],"prefix":"10.1038","volume":"28","author":[{"given":"Michael G.","family":"Argenziano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taruna V.","family":"Neelakantan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Sperring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwaseyi","family":"Adeuyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique M. O.","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6844-0286","authenticated-orcid":false,"given":"Jeffrey N.","family":"Bruce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6890-8355","authenticated-orcid":false,"given":"Betty Y. S.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanassios","family":"Dovas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Canoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0523-3076","authenticated-orcid":false,"given":"Michael","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3532-3868","authenticated-orcid":false,"given":"Brent R.","family":"Stockwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2330-1810","authenticated-orcid":false,"given":"Matei A.","family":"Banu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"key":"1972_CR1","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/nn.3161","volume":"15","author":"SS Ousman","year":"2012","unstructured":"Ousman, S. S. & Kubes, P. Immune surveillance in the central nervous system. Nat. Neurosci. 15, 1096\u20131101 (2012).","journal-title":"Nat. Neurosci."},{"key":"1972_CR2","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1038\/s41556-022-01002-x","volume":"24","author":"KC Kao","year":"2022","unstructured":"Kao, K. C., Vilbois, S., Tsai, C. H. & Ho, P. C. Metabolic communication in the tumour-immune microenvironment. Nat. Cell Biol. 24, 1574\u20131583 (2022).","journal-title":"Nat. Cell Biol."},{"key":"1972_CR3","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.ccell.2023.05.001","volume":"41","author":"JK Minami","year":"2023","unstructured":"Minami, J. K. et al. CDKN2A deletion remodels lipid metabolism to prime glioblastoma for ferroptosis. Cancer Cell 41, 1048\u20131060 e1049 (2023).","journal-title":"Cancer Cell"},{"key":"1972_CR4","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201798772","volume":"37","author":"LB Hoang-Minh","year":"2018","unstructured":"Hoang-Minh, L. B. et al. Infiltrative and drug-resistant slow-cycling cells support metabolic heterogeneity in glioblastoma. EMBO J. 37, e98772 (2018).","journal-title":"EMBO J."},{"key":"1972_CR5","doi-asserted-by":"publisher","first-page":"4492","DOI":"10.1038\/s44318-024-00176-4","volume":"43","author":"MA Banu","year":"2024","unstructured":"Banu, M. A. et al. A cell state-specific metabolic vulnerability to GPX4-dependent ferroptosis in glioblastoma. EMBO J. 43, 4492\u20134521 (2024).","journal-title":"EMBO J."},{"key":"1972_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10493-6","volume":"10","author":"D Henrik Heiland","year":"2019","unstructured":"Henrik Heiland, D. et al. Tumor-associated reactive astrocytes aid the evolution of immunosuppressive environment in glioblastoma. Nat. Commun. 10, 2541 (2019).","journal-title":"Nat. Commun."},{"key":"1972_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36630-w","volume":"14","author":"PS Upadhyayula","year":"2023","unstructured":"Upadhyayula, P. S. et al. Dietary restriction of cysteine and methionine sensitizes gliomas to ferroptosis and induces alterations in energetic metabolism. Nat. Commun. 14, 1187 (2023).","journal-title":"Nat. Commun."},{"key":"1972_CR8","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/s41590-021-00996-0","volume":"22","author":"Y Yao","year":"2021","unstructured":"Yao, Y. et al. Selenium-GPX4 axis protects follicular helper T cells from ferroptosis. Nat. Immunol. 22, 1127\u20131139 (2021).","journal-title":"Nat. Immunol."},{"key":"1972_CR9","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","volume":"185","author":"BR Stockwell","year":"2022","unstructured":"Stockwell, B. R. Ferroptosis turns 10: emerging mechanisms, physiological functions and therapeutic applications. Cell 185, 2401\u20132421 (2022).","journal-title":"Cell"},{"key":"1972_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48734-y","volume":"15","author":"M Osetrova","year":"2024","unstructured":"Osetrova, M. et al. Lipidome atlas of the adult human brain. Nat. Commun. 15, 4455 (2024).","journal-title":"Nat. Commun."},{"key":"1972_CR11","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nchembio.2238","volume":"13","author":"VE Kagan","year":"2017","unstructured":"Kagan, V. E. et al. Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nat. Chem. Biol. 13, 81\u201390 (2017).","journal-title":"Nat. Chem. Biol."},{"key":"1972_CR12","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1126\/science.aaw9872","volume":"368","author":"MA Badgley","year":"2020","unstructured":"Badgley, M. A. et al. Cysteine depletion induces pancreatic tumor ferroptosis in mice. Science 368, 85\u201389 (2020).","journal-title":"Science"},{"key":"1972_CR13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature14344","volume":"520","author":"L Jiang","year":"2015","unstructured":"Jiang, L. et al. Ferroptosis as a p53-mediated activity during tumour suppression. Nature 520, 57\u201362 (2015).","journal-title":"Nature"},{"key":"1972_CR14","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/s41556-018-0178-0","volume":"20","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y. et al. BAP1 links metabolic regulation of ferroptosis to tumour suppression. Nat. Cell Biol. 20, 1181\u20131192 (2018).","journal-title":"Nat. Cell Biol."},{"key":"1972_CR15","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ccell.2014.11.019","volume":"27","author":"IS Harris","year":"2015","unstructured":"Harris, I. S. et al. Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression. Cancer Cell 27, 211\u2013222 (2015).","journal-title":"Cancer Cell"},{"key":"1972_CR16","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature24297","volume":"551","author":"MJ Hangauer","year":"2017","unstructured":"Hangauer, M. J. et al. Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition. Nature 551, 247\u2013250 (2017).","journal-title":"Nature"},{"key":"1972_CR17","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41586-020-2623-z","volume":"585","author":"JM Ubellacker","year":"2020","unstructured":"Ubellacker, J. M. et al. Lymph protects metastasizing melanoma cells from ferroptosis. Nature 585, 113\u2013118 (2020).","journal-title":"Nature"},{"key":"1972_CR18","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41418-022-01096-8","volume":"30","author":"F Muller","year":"2023","unstructured":"Muller, F. et al. Elevated FSP1 protects KRAS-mutated cells from ferroptosis during tumor initiation. Cell Death Differ. 30, 442\u2013456 (2023).","journal-title":"Cell Death Differ."},{"key":"1972_CR19","doi-asserted-by":"publisher","first-page":"9433","DOI":"10.1073\/pnas.1821323116","volume":"116","author":"JKM Lim","year":"2019","unstructured":"Lim, J. K. M. et al. Cystine\/glutamate antiporter xCT (SLC7A11) facilitates oncogenic RAS transformation by preserving intracellular redox balance. Proc. Natl Acad. Sci. USA 116, 9433\u20139442 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1972_CR20","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41586-020-2732-8","volume":"585","author":"Y Zou","year":"2020","unstructured":"Zou, Y. et al. Plasticity of ether lipids promotes ferroptosis susceptibility and evasion. Nature 585, 603\u2013608 (2020).","journal-title":"Nature"},{"key":"1972_CR21","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1101\/gad.334219.119","volume":"34","author":"D Venkatesh","year":"2020","unstructured":"Venkatesh, D. et al. MDM2 and MDMX promote ferroptosis by PPAR\u03b1-mediated lipid remodeling. Genes Dev. 34, 526\u2013543 (2020).","journal-title":"Genes Dev."},{"key":"1972_CR22","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang, X., Stockwell, B. R. & Conrad, M. Ferroptosis: mechanisms, biology and role in disease. Nat. Rev. Mol. Cell Biol. 22, 266\u2013282 (2021).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1972_CR23","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1038\/s41556-024-01360-8","volume":"26","author":"E Dai","year":"2024","unstructured":"Dai, E. et al. A guideline on the molecular ecosystem regulating ferroptosis. Nat. Cell Biol. 26, 1447\u20131457 (2024).","journal-title":"Nat. Cell Biol."},{"key":"1972_CR24","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","volume":"25","author":"SJ Dixon","year":"2024","unstructured":"Dixon, S. J. & Olzmann, J. A. The cell biology of ferroptosis. Nat. Rev. Mol. Cell Biol. 25, 424\u2013442 (2024).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1972_CR25","doi-asserted-by":"publisher","first-page":"101617","DOI":"10.1016\/j.jbc.2022.101617","volume":"298","author":"NE Mbah","year":"2022","unstructured":"Mbah, N. E. & Lyssiotis, C. A. Metabolic regulation of ferroptosis in the tumor microenvironment. J. Biol. Chem. 298, 101617 (2022).","journal-title":"J. Biol. Chem."},{"key":"1972_CR26","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ccell.2024.03.011","volume":"42","author":"G Lei","year":"2024","unstructured":"Lei, G., Zhuang, L. & Gan, B. The roles of ferroptosis in cancer: tumor suppression, tumor microenvironment and therapeutic interventions. Cancer Cell 42, 513\u2013534 (2024).","journal-title":"Cancer Cell"},{"key":"1972_CR27","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","volume":"22","author":"G Lei","year":"2022","unstructured":"Lei, G., Zhuang, L. & Gan, B. Targeting ferroptosis as a vulnerability in cancer. Nat. Rev. Cancer 22, 381\u2013396 (2022).","journal-title":"Nat. Rev. Cancer"},{"key":"1972_CR28","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","volume":"575","author":"K Bersuker","year":"2019","unstructured":"Bersuker, K. et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature 575, 688\u2013692 (2019).","journal-title":"Nature"},{"key":"1972_CR29","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","volume":"575","author":"S Doll","year":"2019","unstructured":"Doll, S. et al. FSP1 is a glutathione-independent ferroptosis suppressor. Nature 575, 693\u2013698 (2019).","journal-title":"Nature"},{"key":"1972_CR30","doi-asserted-by":"publisher","first-page":"E9","DOI":"10.1038\/s41586-023-06269-0","volume":"619","author":"E Mishima","year":"2023","unstructured":"Mishima, E. et al. DHODH inhibitors sensitize to ferroptosis by FSP1 inhibition. Nature 619, E9\u2013E18 (2023).","journal-title":"Nature"},{"key":"1972_CR31","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1093\/neuonc\/noy012","volume":"20","author":"AN Tran","year":"2018","unstructured":"Tran, A. N. et al. Reactive species balance via GTP cyclohydrolase I regulates glioblastoma growth and tumor initiating cell maintenance. Neuro Oncol. 20, 1055\u20131067 (2018).","journal-title":"Neuro Oncol."},{"key":"1972_CR32","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.cell.2015.04.012","volume":"161","author":"HS Venkatesh","year":"2015","unstructured":"Venkatesh, H. S. et al. Neuronal activity promotes glioma growth through neuroligin-3 secretion. Cell 161, 803\u2013816 (2015).","journal-title":"Cell"},{"key":"1972_CR33","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/nature24014","volume":"549","author":"HS Venkatesh","year":"2017","unstructured":"Venkatesh, H. S. et al. Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma. Nature 549, 533\u2013537 (2017).","journal-title":"Nature"},{"key":"1972_CR34","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","volume":"162","author":"CH Chang","year":"2015","unstructured":"Chang, C. H. et al. Metabolic competition in the tumor microenvironment is a driver of cancer progression. Cell 162, 1229\u20131241 (2015).","journal-title":"Cell"},{"key":"1972_CR35","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41586-020-03045-2","volume":"591","author":"MJ Watson","year":"2021","unstructured":"Watson, M. J. et al. Metabolic support of tumour-infiltrating regulatory T cells by lactic acid. Nature 591, 645\u2013651 (2021).","journal-title":"Nature"},{"key":"1972_CR36","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41556-020-0461-8","volume":"22","author":"H Lee","year":"2020","unstructured":"Lee, H. et al. Energy-stress-mediated AMPK activation inhibits ferroptosis. Nat. Cell Biol. 22, 225\u2013234 (2020).","journal-title":"Nat. Cell Biol."},{"key":"1972_CR37","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/j.cell.2014.11.025","volume":"159","author":"T Mashimo","year":"2014","unstructured":"Mashimo, T. et al. Acetate is a bioenergetic substrate for human glioblastoma and brain metastases. Cell 159, 1603\u20131614 (2014).","journal-title":"Cell"},{"key":"1972_CR38","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature13490","volume":"513","author":"OR Colegio","year":"2014","unstructured":"Colegio, O. R. et al. Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature 513, 559\u2013563 (2014).","journal-title":"Nature"},{"key":"1972_CR39","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","volume":"24","author":"A Brand","year":"2016","unstructured":"Brand, A. et al. LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells. Cell Metab. 24, 657\u2013671 (2016).","journal-title":"Cell Metab."},{"key":"1972_CR40","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.cmet.2016.12.018","volume":"25","author":"A Angelin","year":"2017","unstructured":"Angelin, A. et al. Foxp3 reprograms T cell metabolism to function in low-glucose, high-lactate environments. Cell Metab. 25, 1282\u20131293.e1287 (2017).","journal-title":"Cell Metab."},{"key":"1972_CR41","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.immuni.2024.04.006","volume":"57","author":"A De Leo","year":"2024","unstructured":"De Leo, A. et al. Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma. Immunity 57, 1105\u20131123 e1108 (2024).","journal-title":"Immunity"},{"key":"1972_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108487","volume":"33","author":"Y Zhao","year":"2020","unstructured":"Zhao, Y. et al. HCAR1\/MCT1 regulates tumor ferroptosis through the lactate-mediated AMPK-SCD1 activity and its therapeutic implications. Cell Rep. 33, 108487 (2020).","journal-title":"Cell Rep."},{"key":"1972_CR43","doi-asserted-by":"publisher","first-page":"4512","DOI":"10.1038\/s41388-022-02445-0","volume":"41","author":"Y Zhan","year":"2022","unstructured":"Zhan, Y. et al. Dual role of pseudogene TMEM198B in promoting lipid metabolism and immune escape of glioma cells. Oncogene 41, 4512\u20134523 (2022).","journal-title":"Oncogene"},{"key":"1972_CR44","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41590-019-0589-5","volume":"21","author":"H Wang","year":"2020","unstructured":"Wang, H. et al. CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors. Nat. Immunol. 21, 298\u2013308 (2020).","journal-title":"Nat. Immunol."},{"key":"1972_CR45","doi-asserted-by":"publisher","first-page":"3288","DOI":"10.1093\/brain\/awac222","volume":"145","author":"R Perelroizen","year":"2022","unstructured":"Perelroizen, R. et al. Astrocyte immunometabolic regulation of the tumour microenvironment drives glioblastoma pathogenicity. Brain 145, 3288\u20133307 (2022).","journal-title":"Brain"},{"key":"1972_CR46","doi-asserted-by":"publisher","first-page":"106327","DOI":"10.1016\/j.nbd.2023.106327","volume":"188","author":"M Jara\u00edz-Rodr\u00edguez","year":"2023","unstructured":"Jara\u00edz-Rodr\u00edguez, M., Del Prado, L. & Balsa, E. Metabolic remodeling in astrocytes: paving the path to brain tumor development. Neurobiol. Dis. 188, 106327 (2023).","journal-title":"Neurobiol. Dis."},{"key":"1972_CR47","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/s43018-023-00556-5","volume":"4","author":"DC Watson","year":"2023","unstructured":"Watson, D. C. et al. GAP43-dependent mitochondria transfer from astrocytes enhances glioblastoma tumorigenicity. Nat. Cancer 4, 648\u2013664 (2023).","journal-title":"Nat. Cancer"},{"key":"1972_CR48","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.cell.2024.01.030","volume":"187","author":"B Qiu","year":"2024","unstructured":"Qiu, B. et al. Phospholipids with two polyunsaturated fatty acyl tails promote ferroptosis. Cell 187, 1177\u20131190 e1118 (2024).","journal-title":"Cell"},{"key":"1972_CR49","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41586-025-09162-0","volume":"644","author":"D Calhoon","year":"2025","unstructured":"Calhoon, D. et al. Glycosaminoglycan-driven lipoprotein uptake protects tumours from ferroptosis. Nature 644, 799\u2013808 (2025).","journal-title":"Nature"},{"key":"1972_CR50","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.cell.2018.08.038","volume":"175","author":"SK McBrayer","year":"2018","unstructured":"McBrayer, S. K. et al. Transaminase inhibition by 2-hydroxyglutarate impairs glutamate biosynthesis and redox homeostasis in glioma. Cell 175, 101\u2013116 e125 (2018).","journal-title":"Cell"},{"key":"1972_CR51","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1016\/j.celrep.2017.07.054","volume":"20","author":"EM Palmieri","year":"2017","unstructured":"Palmieri, E. M. et al. Pharmacologic or genetic targeting of glutamine synthetase skews macrophages toward an M1-like phenotype and inhibits tumor metastasis. Cell Rep. 20, 1654\u20131666 (2017).","journal-title":"Cell Rep."},{"key":"1972_CR52","doi-asserted-by":"publisher","first-page":"ra97","DOI":"10.1126\/scisignal.aab2610","volume":"8","author":"D Klysz","year":"2015","unstructured":"Klysz, D. et al. Glutamine-dependent \u03b1-ketoglutarate production regulates the balance between T helper 1 cell and regulatory T cell generation. Sci. Signal. 8, ra97 (2015).","journal-title":"Sci. Signal."},{"key":"1972_CR53","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.immuni.2014.04.007","volume":"40","author":"M Nakaya","year":"2014","unstructured":"Nakaya, M. et al. Inflammatory T cell responses rely on amino acid transporter ASCT2 facilitation of glutamine uptake and mTORC1 kinase activation. Immunity 40, 692\u2013705 (2014).","journal-title":"Immunity"},{"key":"1972_CR54","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1038\/ncb3272","volume":"17","author":"S Tardito","year":"2015","unstructured":"Tardito, S. et al. Glutamine synthetase activity fuels nucleotide biosynthesis and supports growth of glutamine-restricted glioblastoma. Nat. Cell Biol. 17, 1556\u20131568 (2015).","journal-title":"Nat. Cell Biol."},{"key":"1972_CR55","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s43018-022-00348-3","volume":"3","author":"BJ Golbourn","year":"2022","unstructured":"Golbourn, B. J. et al. Loss of MAT2A compromises methionine metabolism and represents a vulnerability in H3K27M mutant glioma by modulating the epigenome. Nat. Cancer 3, 629\u2013648 (2022).","journal-title":"Nat. Cancer"},{"key":"1972_CR56","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41586-020-2682-1","volume":"585","author":"Y Bian","year":"2020","unstructured":"Bian, Y. et al. Cancer SLC43A2 alters T cell methionine metabolism and histone methylation. Nature 585, 277\u2013282 (2020).","journal-title":"Nature"},{"key":"1972_CR57","doi-asserted-by":"publisher","first-page":"11455","DOI":"10.1074\/jbc.274.17.11455","volume":"274","author":"H Sato","year":"1999","unstructured":"Sato, H., Tamba, M., Ishii, T. & Bannai, S. Cloning and expression of a plasma membrane cystine\/glutamate exchange transporter composed of two distinct proteins. J. Biol. Chem. 274, 11455\u201311458 (1999).","journal-title":"J. Biol. Chem."},{"key":"1972_CR58","volume":"3","author":"A Cano-Galiano","year":"2021","unstructured":"Cano-Galiano, A. et al. Cystathionine-\u03b3-lyase drives antioxidant defense in cysteine-restricted IDH1-mutant astrocytomas. Neurooncol. Adv. 3, vdab057 (2021).","journal-title":"Neurooncol. Adv."},{"key":"1972_CR59","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nchembio.212","volume":"5","author":"Z Yan","year":"2009","unstructured":"Yan, Z., Garg, S. K., Kipnis, J. & Banerjee, R. Extracellular redox modulation by regulatory T cells. Nat. Chem. Biol. 5, 721\u2013723 (2009).","journal-title":"Nat. Chem. Biol."},{"key":"1972_CR60","doi-asserted-by":"publisher","first-page":"6436","DOI":"10.1073\/pnas.0912827107","volume":"107","author":"A Nabeyama","year":"2010","unstructured":"Nabeyama, A. et al. xCT deficiency accelerates chemically induced tumorigenesis. Proc. Natl Acad. Sci. USA 107, 6436\u20136441 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1972_CR61","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/s41573-024-00920-9","volume":"23","author":"L Galluzzi","year":"2024","unstructured":"Galluzzi, L., Guilbaud, E., Schmidt, D., Kroemer, G. & Marincola, F. M. Targeting immunogenic cell stress and death for cancer therapy. Nat. Rev. Drug Discov. 23, 445\u2013460 (2024).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1972_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15129-8","volume":"11","author":"CA von Roemeling","year":"2020","unstructured":"von Roemeling, C. A. et al. Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity. Nat. Commun. 11, 1508 (2020).","journal-title":"Nat. Commun."},{"key":"1972_CR63","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/s41419-020-03221-2","volume":"11","author":"J Fucikova","year":"2020","unstructured":"Fucikova, J. et al. Detection of immunogenic cell death and its relevance for cancer therapy. Cell Death Dis. 11, 1013 (2020).","journal-title":"Cell Death Dis."},{"key":"1972_CR64","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.trecan.2017.07.002","volume":"3","author":"N Rufo","year":"2017","unstructured":"Rufo, N., Garg, A. D. & Agostinis, P. The unfolded protein response in immunogenic cell death and cancer immunotherapy. Trends Cancer 3, 643\u2013658 (2017).","journal-title":"Trends Cancer"},{"key":"1972_CR65","doi-asserted-by":"publisher","first-page":"4854","DOI":"10.1111\/jcmm.14356","volume":"23","author":"J Zhou","year":"2019","unstructured":"Zhou, J. et al. Immunogenic cell death in cancer therapy: present and emerging inducers. J. Cell. Mol. Med. 23, 4854\u20134865 (2019).","journal-title":"J. Cell. Mol. Med."},{"key":"1972_CR66","doi-asserted-by":"publisher","first-page":"3978","DOI":"10.4049\/jimmunol.169.7.3978","volume":"169","author":"RW Vandivier","year":"2002","unstructured":"Vandivier, R. W. et al. Role of surfactant proteins A, D and C1q in the clearance of apoptotic cells in vivo and in vitro: calreticulin and CD91 as a common collectin receptor complex. J. Immunol. 169, 3978\u20133986 (2002).","journal-title":"J. Immunol."},{"key":"1972_CR67","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.3389\/fimmu.2017.01034","volume":"8","author":"R Osman","year":"2017","unstructured":"Osman, R., Tacnet-Delorme, P., Kleman, J. P., Millet, A. & Frachet, P. Calreticulin release at an early stage of death modulates the clearance by macrophages of apoptotic cells. Front. Immunol. 8, 1034 (2017).","journal-title":"Front. Immunol."},{"key":"1972_CR68","doi-asserted-by":"publisher","first-page":"7941","DOI":"10.1158\/0008-5472.CAN-07-1622","volume":"67","author":"M Obeid","year":"2007","unstructured":"Obeid, M. et al. Leveraging the immune system during chemotherapy: moving calreticulin to the cell surface converts apoptotic death from \u2018silent\u2019 to immunogenic. Cancer Res. 67, 7941\u20137944 (2007).","journal-title":"Cancer Res."},{"key":"1972_CR69","doi-asserted-by":"publisher","first-page":"e02523","DOI":"10.7554\/eLife.02523","volume":"3","author":"SJ Dixon","year":"2014","unstructured":"Dixon, S. J. et al. Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis. eLife 3, e02523 (2014).","journal-title":"eLife"},{"key":"1972_CR70","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adg3049","volume":"15","author":"J Li","year":"2023","unstructured":"Li, J. et al. Tumor-specific GPX4 degradation enhances ferroptosis-initiated antitumor immune response in mouse models of pancreatic cancer. Sci. Transl. Med. 15, eadg3049 (2023).","journal-title":"Sci. Transl. Med."},{"key":"1972_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31218-2","volume":"13","author":"B Wiernicki","year":"2022","unstructured":"Wiernicki, B. et al. Cancer cells dying from ferroptosis impede dendritic cell-mediated anti-tumor immunity. Nat. Commun. 13, 3676 (2022).","journal-title":"Nat. Commun."},{"key":"1972_CR72","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1038\/s41418-025-01517-4","volume":"32","author":"FI Yapici","year":"2025","unstructured":"Yapici, F. I. et al. An atlas of ferroptosis-induced secretomes. Cell Death Differ. 32, 1986\u20132008 (2025).","journal-title":"Cell Death Differ."},{"key":"1972_CR73","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001369","volume":"8","author":"I Efimova","year":"2020","unstructured":"Efimova, I. et al. Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity. J. Immunother. Cancer 8, e001369 (2020).","journal-title":"J. Immunother. Cancer"},{"key":"1972_CR74","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1186\/s40425-019-0826-3","volume":"7","author":"VD Turubanova","year":"2019","unstructured":"Turubanova, V. D. et al. Immunogenic cell death induced by a new photodynamic therapy based on photosens and photodithazine. J. Immunother. Cancer 7, 350 (2019).","journal-title":"J. Immunother. Cancer"},{"key":"1972_CR75","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/S0952-7915(97)80190-2","volume":"9","author":"P Lu","year":"1997","unstructured":"Lu, P., Wang, Y. L. & Linsley, P. S. Regulation of self-tolerance by CD80\/CD86 interactions. Curr. Opin. Immunol. 9, 858\u2013862 (1997).","journal-title":"Curr. Opin. Immunol."},{"key":"1972_CR76","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aau6426","volume":"4","author":"TV Zhao","year":"2019","unstructured":"Zhao, T. V. et al. ATP release drives heightened immune responses associated with hypertension. Sci. Immunol. 4, eaau6426 (2019).","journal-title":"Sci. Immunol."},{"key":"1972_CR77","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1038\/s41418-020-00719-2","volume":"28","author":"X Luo","year":"2021","unstructured":"Luo, X. et al. Oxygenated phosphatidylethanolamine navigates phagocytosis of ferroptotic cells by interacting with TLR2. Cell Death Differ. 28, 1971\u20131989 (2021).","journal-title":"Cell Death Differ."},{"key":"1972_CR78","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1002\/glia.23597","volume":"67","author":"CY Chang","year":"2019","unstructured":"Chang, C. Y. et al. Glial TLR2-driven innate immune responses and CD8+T cell activation against brain tumor. Glia 67, 1179\u20131195 (2019).","journal-title":"Glia"},{"key":"1972_CR79","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/ncb3064","volume":"16","author":"JP Friedmann Angeli","year":"2014","unstructured":"Friedmann Angeli, J. P. et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat. Cell Biol. 16, 1180\u20131191 (2014).","journal-title":"Nat. Cell Biol."},{"key":"1972_CR80","doi-asserted-by":"publisher","first-page":"vii9","DOI":"10.1093\/neuonc\/nov151","volume":"17","author":"EK Nduom","year":"2015","unstructured":"Nduom, E. K., Weller, M. & Heimberger, A. B. Immunosuppressive mechanisms in glioblastoma. Neuro Oncol. 17, vii9\u2013vii14 (2015).","journal-title":"Neuro Oncol."},{"key":"1972_CR81","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1136\/gutjnl-2022-327909","volume":"72","author":"C Conche","year":"2023","unstructured":"Conche, C. et al. Combining ferroptosis induction with MDSC blockade renders primary tumours and metastases in liver sensitive to immune checkpoint blockade. Gut 72, 1774\u20131782 (2023).","journal-title":"Gut"},{"key":"1972_CR82","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.4049\/jimmunol.2000500","volume":"206","author":"H Zhu","year":"2021","unstructured":"Zhu, H. et al. Asah2 represses the p53-Hmox1 axis to protect myeloid-derived suppressor cells from ferroptosis. J. Immunol. 206, 1395\u20131404 (2021).","journal-title":"J. Immunol."},{"key":"1972_CR83","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/s41589-019-0462-8","volume":"16","author":"AA Kapralov","year":"2020","unstructured":"Kapralov, A. A. et al. Redox lipid reprogramming commands susceptibility of macrophages and microglia to ferroptotic death. Nat. Chem. Biol. 16, 278\u2013290 (2020).","journal-title":"Nat. Chem. Biol."},{"key":"1972_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05384-6","volume":"13","author":"Q Dang","year":"2022","unstructured":"Dang, Q. et al. Ferroptosis: a double-edged sword mediating immune tolerance of cancer. Cell Death Dis. 13, 925 (2022).","journal-title":"Cell Death Dis."},{"key":"1972_CR85","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.molmed.2021.06.014","volume":"27","author":"H Xu","year":"2021","unstructured":"Xu, H., Ye, D., Ren, M., Zhang, H. & Bi, F. Ferroptosis in the tumor microenvironment: perspectives for immunotherapy. Trends Mol. Med. 27, 856\u2013867 (2021).","journal-title":"Trends Mol. Med."},{"key":"1972_CR86","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1093\/neuonc\/noac033","volume":"24","author":"T Liu","year":"2022","unstructured":"Liu, T. et al. Ferroptosis, as the most enriched programmed cell death process in glioma, induces immunosuppression and immunotherapy resistance. Neuro Oncol. 24, 1113\u20131125 (2022).","journal-title":"Neuro Oncol."},{"key":"1972_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19193-y","volume":"11","author":"PP Yee","year":"2020","unstructured":"Yee, P. P. et al. Neutrophil-induced ferroptosis promotes tumor necrosis in glioblastoma progression. Nat. Commun. 11, 5424 (2020).","journal-title":"Nat. Commun."},{"key":"1972_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37361-8","volume":"14","author":"Z Chen","year":"2023","unstructured":"Chen, Z. et al. Monocyte depletion enhances neutrophil influx and proneural to mesenchymal transition in glioblastoma. Nat. Commun. 14, 1839 (2023).","journal-title":"Nat. Commun."},{"key":"1972_CR89","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41586-022-05443-0","volume":"612","author":"R Kim","year":"2022","unstructured":"Kim, R. et al. Ferroptosis of tumour neutrophils causes immune suppression in cancer. Nature 612, 338\u2013346 (2022).","journal-title":"Nature"},{"key":"1972_CR90","doi-asserted-by":"publisher","first-page":"e1445458","DOI":"10.1080\/2162402X.2018.1445458","volume":"7","author":"VA Arrieta","year":"2018","unstructured":"Arrieta, V. A. et al. The possibility of cancer immune editing in gliomas. A critical review. Oncoimmunology 7, e1445458 (2018).","journal-title":"Oncoimmunology"},{"key":"1972_CR91","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.cmet.2021.03.023","volume":"33","author":"SM Poznanski","year":"2021","unstructured":"Poznanski, S. M. et al. Metabolic flexibility determines human NK cell functional fate in the tumor microenvironment. Cell Metab. 33, 1205\u20131220 e1205 (2021).","journal-title":"Cell Metab."},{"key":"1972_CR92","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-022-01635-y","volume":"20","author":"KS Kim","year":"2022","unstructured":"Kim, K. S. et al. Enhanced natural killer cell anti-tumor activity with nanoparticles mediated ferroptosis and potential therapeutic application in prostate cancer. J. Nanobiotechnology 20, 428 (2022).","journal-title":"J. Nanobiotechnology"},{"key":"1972_CR93","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.immuni.2008.03.003","volume":"28","author":"MO Li","year":"2008","unstructured":"Li, M. O. & Flavell, R. A. Contextual regulation of inflammation: a duet by transforming growth factor-beta and interleukin-10. Immunity 28, 468\u2013476 (2008).","journal-title":"Immunity"},{"key":"1972_CR94","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1158\/2326-6066.CIR-24-0230","volume":"12","author":"A Pant","year":"2024","unstructured":"Pant, A. et al. The CCR6-CCL20 axis promotes regulatory T-cell glycolysis and immunosuppression in tumors. Cancer Immunol. Res. 12, 1542\u20131558 (2024).","journal-title":"Cancer Immunol. Res."},{"key":"1972_CR95","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1146\/annurev-cancerbio-030419-033428","volume":"4","author":"G Plitas","year":"2020","unstructured":"Plitas, G. & Rudensky, A. Y. Regulatory T cells in cancer. Annu. Rev. Cancer Biol. 4, 459\u2013477 (2020).","journal-title":"Annu. Rev. Cancer Biol."},{"key":"1972_CR96","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.4049\/jimmunol.1101649","volume":"187","author":"W Kastenmuller","year":"2011","unstructured":"Kastenmuller, W. et al. Regulatory T cells selectively control CD8+ T cell effector pool size via IL-2 restriction. J. Immunol. 187, 3186\u20133197 (2011).","journal-title":"J. Immunol."},{"key":"1972_CR97","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.celrep.2019.03.029","volume":"27","author":"J Miska","year":"2019","unstructured":"Miska, J. et al. HIF-1\u03b1 is a metabolic switch between glycolytic-driven migration and oxidative phosphorylation-driven immunosuppression of Tregs in glioblastoma. Cell Rep. 27, 226\u2013237 e224 (2019).","journal-title":"Cell Rep."},{"key":"1972_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109235","volume":"35","author":"C Xu","year":"2021","unstructured":"Xu, C. et al. The glutathione peroxidase Gpx4 prevents lipid peroxidation and ferroptosis to sustain Treg cell activation and suppression of antitumor immunity. Cell Rep. 35, 109235 (2021).","journal-title":"Cell Rep."},{"key":"1972_CR99","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.cmet.2020.03.004","volume":"31","author":"H Kurniawan","year":"2020","unstructured":"Kurniawan, H. et al. Glutathione restricts serine metabolism to preserve regulatory T cell function. Cell Metab. 31, 920\u2013936.e927 (2020).","journal-title":"Cell Metab."},{"key":"1972_CR100","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3389\/fimmu.2013.00116","volume":"4","author":"DA Wainwright","year":"2013","unstructured":"Wainwright, D. A., Dey, M., Chang, A. & Lesniak, M. S. Targeting Tregs in malignant brain cancer: overcoming IDO. Front. Immunol. 4, 116 (2013).","journal-title":"Front. Immunol."},{"key":"1972_CR101","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41556-023-01314-6","volume":"26","author":"W Cui","year":"2024","unstructured":"Cui, W. et al. Gut microbial metabolite facilitates colorectal cancer development via ferroptosis inhibition. Nat. Cell Biol. 26, 124\u2013137 (2024).","journal-title":"Nat. Cell Biol."},{"key":"1972_CR102","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202204006","volume":"10","author":"D Liu","year":"2023","unstructured":"Liu, D. et al. Tryptophan metabolism acts as a new anti-ferroptotic pathway to mediate tumor growth. Adv. Sci. (Weinh) 10, e2204006 (2023).","journal-title":"Adv. Sci. (Weinh)"},{"key":"1972_CR103","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.omtn.2021.05.009","volume":"25","author":"D Bai","year":"2021","unstructured":"Bai, D. et al. Genomic analysis uncovers prognostic and immunogenic characteristics of ferroptosis for clear cell renal cell carcinoma. Mol. Ther. Nucleic Acids 25, 186\u2013197 (2021).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"1972_CR104","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.791630","volume":"10","author":"J Liu","year":"2022","unstructured":"Liu, J. et al. Ferroptosis mediation patterns reveal novel tool to implicate immunotherapy and multi-omics characteristics in bladder cancer. Front. Cell Dev. Biol. 10, 791630 (2022).","journal-title":"Front. Cell Dev. Biol."},{"key":"1972_CR105","doi-asserted-by":"publisher","first-page":"3998","DOI":"10.1016\/j.cell.2021.05.027","volume":"184","author":"F Marangoni","year":"2021","unstructured":"Marangoni, F. et al. Expansion of tumor-associated Treg cells upon disruption of a CTLA-4-dependent feedback loop. Cell 184, 3998\u20134015.e3919 (2021).","journal-title":"Cell"},{"key":"1972_CR106","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1158\/0008-5472.CAN-19-1577","volume":"80","author":"Y Long","year":"2020","unstructured":"Long, Y. et al. Dysregulation of glutamate transport enhances Treg function that promotes VEGF blockade resistance in glioblastoma. Cancer Res. 80, 499\u2013509 (2020).","journal-title":"Cancer Res."},{"key":"1972_CR107","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.cell.2015.05.025","volume":"161","author":"JR Cubillos-Ruiz","year":"2015","unstructured":"Cubillos-Ruiz, J. R. et al. ER stress sensor XBP1 controls anti-tumor immunity by disrupting dendritic cell homeostasis. Cell 161, 1527\u20131538 (2015).","journal-title":"Cell"},{"key":"1972_CR108","doi-asserted-by":"publisher","first-page":"4399","DOI":"10.1016\/j.celrep.2020.03.019","volume":"30","author":"J Muri","year":"2020","unstructured":"Muri, J. et al. Cyclopentenone prostaglandins and structurally related oxidized lipid species instigate and share distinct pro- and anti-inflammatory pathways. Cell Rep. 30, 4399\u20134417 e4397 (2020).","journal-title":"Cell Rep."},{"key":"1972_CR109","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-022-01360-6","volume":"20","author":"B Liu","year":"2022","unstructured":"Liu, B. et al. Biomimetic GBM-targeted drug delivery system boosting ferroptosis for immunotherapy of orthotopic drug-resistant GBM. J. Nanobiotechnology 20, 161 (2022).","journal-title":"J. Nanobiotechnology"},{"key":"1972_CR110","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1093\/intimm\/dxs051","volume":"24","author":"CA Wild","year":"2012","unstructured":"Wild, C. A. et al. HMGB1 conveys immunosuppressive characteristics on regulatory and conventional T cells. Int. Immunol. 24, 485\u2013494 (2012).","journal-title":"Int. Immunol."},{"key":"1972_CR111","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1158\/1535-7163.MCT-05-0548","volume":"5","author":"T Payner","year":"2006","unstructured":"Payner, T. et al. Microsomal prostaglandin E synthase-1 regulates human glioma cell growth via prostaglandin E(2)-dependent activation of type II protein kinase A. Mol. Cancer Ther. 5, 1817\u20131826 (2006).","journal-title":"Mol. Cancer Ther."},{"key":"1972_CR112","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.trecan.2016.12.002","volume":"3","author":"J Jiang","year":"2017","unstructured":"Jiang, J., Qiu, J., Li, Q. & Shi, Z. Prostaglandin E2 signaling: alternative target for glioblastoma? Trends Cancer 3, 75\u201378 (2017).","journal-title":"Trends Cancer"},{"key":"1972_CR113","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41586-019-1118-2","volume":"569","author":"F Veglia","year":"2019","unstructured":"Veglia, F. et al. Fatty acid transport protein 2 reprograms neutrophils in cancer. Nature 569, 73\u201378 (2019).","journal-title":"Nature"},{"key":"1972_CR114","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4049\/jimmunol.1101029","volume":"188","author":"P Kalinski","year":"2012","unstructured":"Kalinski, P. Regulation of immune responses by prostaglandin E2. J. Immunol. 188, 21\u201328 (2012).","journal-title":"J. Immunol."},{"key":"1972_CR115","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.cell.2018.01.004","volume":"172","author":"JP B\u00f6ttcher","year":"2018","unstructured":"B\u00f6ttcher, J. P. et al. NK cells stimulate recruitment of cDC1 into the tumor microenvironment promoting cancer immune control. Cell 172, 1022\u20131037.e1014 (2018).","journal-title":"Cell"},{"key":"1972_CR116","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.4049\/jimmunol.175.3.1483","volume":"175","author":"F Baratelli","year":"2005","unstructured":"Baratelli, F. et al. Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells. J. Immunol. 175, 1483\u20131490 (2005).","journal-title":"J. Immunol."},{"key":"1972_CR117","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.ccell.2017.11.004","volume":"32","author":"O Canli","year":"2017","unstructured":"Canli, O. et al. Myeloid cell-derived reactive oxygen species induce epithelial mutagenesis. Cancer Cell 32, 869\u2013883 e865 (2017).","journal-title":"Cancer Cell"},{"key":"1972_CR118","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20154-8","volume":"11","author":"E Dai","year":"2020","unstructured":"Dai, E. et al. Ferroptotic damage promotes pancreatic tumorigenesis through a TMEM173\/STING-dependent DNA sensor pathway. Nat. Commun. 11, 6339 (2020).","journal-title":"Nat. Commun."},{"key":"1972_CR119","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.cmet.2021.02.015","volume":"33","author":"X Ma","year":"2021","unstructured":"Ma, X. et al. CD36-mediated ferroptosis dampens intratumoral CD8+ T cell effector function and impairs their antitumor ability. Cell Metab. 33, 1001\u20131012 e1005 (2021).","journal-title":"Cell Metab."},{"key":"1972_CR120","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1158\/2326-6066.CIR-20-0384","volume":"9","author":"JM Drijvers","year":"2021","unstructured":"Drijvers, J. M. et al. Pharmacologic screening identifies metabolic vulnerabilities of CD8+ T cells. Cancer Immunol. Res. 9, 184\u2013199 (2021).","journal-title":"Cancer Immunol. Res."},{"key":"1972_CR121","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/j.immuni.2021.05.003","volume":"54","author":"S Xu","year":"2021","unstructured":"Xu, S. et al. Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8+ T cells in tumors. Immunity 54, 1561\u20131577 e1567 (2021).","journal-title":"Immunity"},{"key":"1972_CR122","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1016\/j.celrep.2019.10.070","volume":"29","author":"J Muri","year":"2019","unstructured":"Muri, J., Thut, H., Bornkamm, G. W. & Kopf, M. B1 and marginal zone B cells but not follicular B2 cells require Gpx4 to prevent lipid peroxidation and ferroptosis. Cell Rep. 29, 2731\u20132744 e2734 (2019).","journal-title":"Cell Rep."},{"key":"1972_CR123","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.ccell.2022.02.003","volume":"40","author":"P Liao","year":"2022","unstructured":"Liao, P. et al. CD8+ T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4. Cancer Cell 40, 365\u2013378 e366 (2022).","journal-title":"Cancer Cell"},{"key":"1972_CR124","doi-asserted-by":"publisher","first-page":"9533","DOI":"10.1073\/pnas.1814932116","volume":"116","author":"MD Arensman","year":"2019","unstructured":"Arensman, M. D. et al. Cystine-glutamate antiporter xCT deficiency suppresses tumor growth while preserving antitumor immunity. Proc. Natl Acad. Sci. USA 116, 9533\u20139542 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1972_CR125","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41589-020-0501-5","volume":"16","author":"JK Eaton","year":"2020","unstructured":"Eaton, J. K. et al. Selective covalent targeting of GPX4 using masked nitrile-oxide electrophiles. Nat. Chem. Biol. 16, 497\u2013506 (2020).","journal-title":"Nat. Chem. Biol."},{"key":"1972_CR126","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/s41571-018-0003-5","volume":"15","author":"M Lim","year":"2018","unstructured":"Lim, M., Xia, Y., Bettegowda, C. & Weller, M. Current state of immunotherapy for glioblastoma. Nat. Rev. Clin. Oncol. 15, 422\u2013442 (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1972_CR127","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1001\/jamaoncol.2020.1024","volume":"6","author":"DA Reardon","year":"2020","unstructured":"Reardon, D. A. et al. Effect of nivolumab vs bevacizumab in patients with recurrent glioblastoma: the CheckMate 143 phase 3 randomized clinical trial. JAMA Oncol. 6, 1003\u20131010 (2020).","journal-title":"JAMA Oncol."},{"key":"1972_CR128","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.1200\/JCO-25-00618","volume":"43","author":"AB Lassman","year":"2025","unstructured":"Lassman, A. B. et al. Dual immune check point blockade in MGMT-unmethylated newly diagnosed glioblastoma: NRG Oncology BN007, a randomized phase II\/III clinical trial. J. Clin. Oncol. 43, 3032\u20133040 (2025).","journal-title":"J. Clin. Oncol."},{"key":"1972_CR129","doi-asserted-by":"publisher","DOI":"10.1172\/JCI163447","volume":"133","author":"VA Arrieta","year":"2023","unstructured":"Arrieta, V. A. et al. Immune checkpoint blockade in glioblastoma: from tumor heterogeneity to personalized treatment. J. Clin. Invest. 133, e163447 (2023).","journal-title":"J. Clin. Invest."},{"key":"1972_CR130","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cmet.2022.09.021","volume":"35","author":"F Yang","year":"2023","unstructured":"Yang, F. et al. Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy. Cell Metab. 35, 84\u2013100 e108 (2023).","journal-title":"Cell Metab."},{"key":"1972_CR131","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40518-0","volume":"14","author":"Y Xue","year":"2023","unstructured":"Xue, Y. et al. Intermittent dietary methionine deprivation facilitates tumoral ferroptosis and synergizes with checkpoint blockade. Nat. Commun. 14, 4758 (2023).","journal-title":"Nat. Commun."},{"key":"1972_CR132","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","volume":"569","author":"W Wang","year":"2019","unstructured":"Wang, W. et al. CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy. Nature 569, 270\u2013274 (2019).","journal-title":"Nature"},{"key":"1972_CR133","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1158\/2159-8290.CD-19-0338","volume":"9","author":"X Lang","year":"2019","unstructured":"Lang, X. et al. Radiotherapy and immunotherapy promote tumoral lipid oxidation and ferroptosis via synergistic repression of SLC7A11. Cancer Discov. 9, 1673\u20131685 (2019).","journal-title":"Cancer Discov."},{"key":"1972_CR134","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.ccell.2022.02.003","volume":"40","author":"P Liao","year":"2022","unstructured":"Liao, P. et al. CD8+ T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4. Cancer Cell 40, 365\u2013378.e366 (2022).","journal-title":"Cancer Cell"},{"key":"1972_CR135","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1016\/j.ccell.2024.10.010","volume":"42","author":"H Lin","year":"2024","unstructured":"Lin, H. et al. Itaconate transporter SLC13A3 impairs tumor immunity via endowing ferroptosis resistance. Cancer Cell 42, 2032\u20132044 e2036 (2024).","journal-title":"Cancer Cell"},{"key":"1972_CR136","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202114323","volume":"13","author":"S Hirschberger","year":"2021","unstructured":"Hirschberger, S. et al. Very-low-carbohydrate diet enhances human T-cell immunity through immunometabolic reprogramming. EMBO Mol. Med. 13, e14323 (2021).","journal-title":"EMBO Mol. Med."},{"key":"1972_CR137","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41586-018-0343-4","volume":"560","author":"BD Hopkins","year":"2018","unstructured":"Hopkins, B. D. et al. Suppression of insulin feedback enhances the efficacy of PI3K inhibitors. Nature 560, 499\u2013503 (2018).","journal-title":"Nature"},{"key":"1972_CR138","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115825","volume":"44","author":"HC Kim","year":"2025","unstructured":"Kim, H. C. et al. Gut microbiota dysbiosis induced by brain tumors modulates the efficacy of immunotherapy. Cell Rep. 44, 115825 (2025).","journal-title":"Cell Rep."},{"key":"1972_CR139","doi-asserted-by":"publisher","DOI":"10.1172\/JCI139434","volume":"131","author":"Z Jiang","year":"2021","unstructured":"Jiang, Z. et al. TYRO3 induces anti-PD-1\/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis. J. Clin. Invest. 131, e139434 (2021).","journal-title":"J. Clin. Invest."},{"key":"1972_CR140","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrp.2024.102221","volume":"5","author":"X Wang","year":"2024","unstructured":"Wang, X. et al. Bimetallic nanodot-adenovirus chimera for cancer theranostics via cooperativity of autophagy and ferroptosis. Cell Rep. Phys. Sci. 5, 102221 (2024).","journal-title":"Cell Rep. Phys. Sci."},{"key":"1972_CR141","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41586-023-06623-2","volume":"623","author":"AL Ling","year":"2023","unstructured":"Ling, A. L. et al. Clinical trial links oncolytic immunoactivation to survival in glioblastoma. Nature 623, 157\u2013166 (2023).","journal-title":"Nature"},{"key":"1972_CR142","doi-asserted-by":"publisher","first-page":"6233","DOI":"10.1158\/0008-5472.CAN-21-1547","volume":"81","author":"F Fan","year":"2021","unstructured":"Fan, F. et al. A dual PI3K\/HDAC inhibitor induces immunogenic ferroptosis to potentiate cancer immune checkpoint therapy. Cancer Res. 81, 6233\u20136245 (2021).","journal-title":"Cancer Res."},{"key":"1972_CR143","doi-asserted-by":"publisher","first-page":"E761","DOI":"10.1073\/pnas.1620433114","volume":"114","author":"K Chamoto","year":"2017","unstructured":"Chamoto, K. et al. Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity. Proc. Natl Acad. Sci. USA 114, E761\u2013E770 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1972_CR144","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/s41586-025-09460-7","volume":"646","author":"AJ Scott","year":"2025","unstructured":"Scott, A. J. et al. Rewiring of cortical glucose metabolism fuels human brain cancer growth. Nature 646, 413\u2013422 (2025).","journal-title":"Nature"},{"key":"1972_CR145","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.cmet.2019.06.014","volume":"30","author":"J Bi","year":"2019","unstructured":"Bi, J. et al. Oncogene amplification in growth factor signaling pathways renders cancers dependent on membrane lipid remodeling. Cell Metab. 30, 525\u2013538 e528 (2019).","journal-title":"Cell Metab."},{"key":"1972_CR146","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1038\/nm.4418","volume":"23","author":"WX Mai","year":"2017","unstructured":"Mai, W. X. et al. Cytoplasmic p53 couples oncogene-driven glucose metabolism to apoptosis and is a therapeutic target in glioblastoma. Nat. Med. 23, 1342\u20131351 (2017).","journal-title":"Nat. Med."},{"key":"1972_CR147","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20752-6","volume":"12","author":"A Lita","year":"2021","unstructured":"Lita, A. et al. IDH1 mutations induce organelle defects via dysregulated phospholipids. Nat. Commun. 12, 614 (2021).","journal-title":"Nat. Commun."},{"key":"1972_CR148","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.ccell.2020.07.008","volume":"38","author":"C Chung","year":"2020","unstructured":"Chung, C. et al. Integrated metabolic and epigenomic reprograming by H3K27M mutations in diffuse intrinsic pontine gliomas. Cancer Cell 38, 334\u2013349 e339 (2020).","journal-title":"Cancer Cell"},{"key":"1972_CR149","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ccell.2021.01.006","volume":"39","author":"LB Wang","year":"2021","unstructured":"Wang, L. B. et al. Proteogenomic and metabolomic characterization of human glioblastoma. Cancer Cell 39, 509\u2013528 e520 (2021).","journal-title":"Cancer Cell"},{"key":"1972_CR150","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1016\/j.celrep.2017.02.054","volume":"18","author":"I Poursaitidis","year":"2017","unstructured":"Poursaitidis, I. et al. Oncogene-selective sensitivity to synchronous cell death following modulation of the amino acid nutrient cystine. Cell Rep. 18, 2547\u20132556 (2017).","journal-title":"Cell Rep."},{"key":"1972_CR151","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1016\/j.celrep.2017.07.055","volume":"20","author":"Y Xie","year":"2017","unstructured":"Xie, Y. et al. The tumor suppressor p53 limits ferroptosis by blocking DPP4 activity. Cell Rep. 20, 1692\u20131704 (2017).","journal-title":"Cell Rep."},{"key":"1972_CR152","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/s41557-020-0513-5","volume":"12","author":"S Muller","year":"2020","unstructured":"Muller, S. et al. CD44 regulates epigenetic plasticity by mediating iron endocytosis. Nat. Chem. 12, 929\u2013938 (2020).","journal-title":"Nat. Chem."},{"key":"1972_CR153","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1158\/1078-0432.CCR-22-3179","volume":"29","author":"Y Liu","year":"2023","unstructured":"Liu, Y. et al. Protein Kinase B (PKB\/AKT) protects IDH-mutated glioma from ferroptosis via Nrf2. Clin. Cancer Res. 29, 1305\u20131316 (2023).","journal-title":"Clin. Cancer Res."},{"key":"1972_CR154","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1984-4","volume":"10","author":"TX Wang","year":"2019","unstructured":"Wang, T. X. et al. The oncometabolite 2-hydroxyglutarate produced by mutant IDH1 sensitizes cells to ferroptosis. Cell Death Dis. 10, 755 (2019).","journal-title":"Cell Death Dis."},{"key":"1972_CR155","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15041249","volume":"15","author":"A Pan","year":"2023","unstructured":"Pan, A. & Lim, M. CAR-T therapy in GBM: current challenges and avenues for improvement. Cancers (Basel) 15, 1249 (2023).","journal-title":"Cancers (Basel)"},{"key":"1972_CR156","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaa0984","volume":"9","author":"DM O\u2019Rourke","year":"2017","unstructured":"O\u2019Rourke, D. M. et al. A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma. Sci. Transl. Med. 9, eaaa0984 (2017).","journal-title":"Sci. Transl. Med."},{"key":"1972_CR157","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abq3016","volume":"8","author":"JJ Peng","year":"2023","unstructured":"Peng, J. J., Wang, L., Li, Z., Ku, C. L. & Ho, P. C. Metabolic challenges and interventions in CAR T cell therapy. Sci. Immunol. 8, eabq3016 (2023).","journal-title":"Sci. Immunol."},{"key":"1972_CR158","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41556-017-0002-2","volume":"20","author":"R Ma","year":"2018","unstructured":"Ma, R. et al. A Pck1-directed glycogen metabolic program regulates formation and maintenance of memory CD8+ T cells. Nat. Cell Biol. 20, 21\u201327 (2018).","journal-title":"Nat. Cell Biol."},{"key":"1972_CR159","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1158\/0008-5472.CAN-19-1196","volume":"80","author":"T Kondo","year":"2020","unstructured":"Kondo, T. et al. The NOTCH-FOXM1 axis plays a key role in mitochondrial biogenesis in the induction of human stem cell memory-like CAR-T cells. Cancer Res. 80, 471\u2013483 (2020).","journal-title":"Cancer Res."},{"key":"1972_CR160","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1182\/blood.2019004500","volume":"136","author":"L Fultang","year":"2020","unstructured":"Fultang, L. et al. Metabolic engineering against the arginine microenvironment enhances CAR-T cell proliferation and therapeutic activity. Blood 136, 1155\u20131160 (2020).","journal-title":"Blood"},{"key":"1972_CR161","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46776-w","volume":"15","author":"G Bi","year":"2024","unstructured":"Bi, G. et al. Polyamine-mediated ferroptosis amplification acts as a targetable vulnerability in cancer. Nat. Commun. 15, 2461 (2024).","journal-title":"Nat. Commun."}],"container-title":["Nature Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41556-026-01972-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41556-026-01972-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41556-026-01972-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T22:02:45Z","timestamp":1783980165000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41556-026-01972-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":161,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["1972"],"URL":"https:\/\/doi.org\/10.1038\/s41556-026-01972-2","relation":{},"ISSN":["1465-7392","1476-4679"],"issn-type":[{"value":"1465-7392","type":"print"},{"value":"1476-4679","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]},"assertion":[{"value":"18 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"B.R.S. is an inventor on patents and patent applications involving ferroptosis, has co-founded and serves as consultant to ProJenX, Inc. and Exarta Therapeutics, holds equity in Sonata Therapeutics, and serves as a consultant to Weatherwax Biotechnologies Corporation and Akin Gump Strauss Hauer & Feld LLP. J.N.B. and P.C. are the founders of Convecta Therapeutics, a company developing convection enhanced delivery drug formulations. J.N.B. is also a consultant for Theracle, Inc., which designs catheters for drug delivery to the brain. M.L. has obtained funding from Arbor Pharmaceuticals, Accuray, BMS and Novartis, and serves as consultant for BMS, Merck, SQZ Biotechnologies, Tocagen and VBI. M.L. is a shareholder in Egret Therapeutics. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}